Brazil Non Invasive Prenatal Testing Market Size & Outlook
Brazil non invasive prenatal testing market, 2018-2030 (US$M)
Related Markets
Brazil non invasive prenatal testing market highlights
- The Brazil non invasive prenatal testing market generated a revenue of USD 60.8 million in 2022 and is expected to reach USD 133.1 million by 2030.
- The Brazil market is expected to grow at a CAGR of 10.3% from 2023 to 2030.
- In terms of segment, 13-24 weeks was the largest revenue generating gestation period in 2022.
- 0-12 weeks is the most lucrative gestation period segment registering the fastest growth during the forecast period.
Non invasive prenatal testing market data book summary
| Market revenue in 2022 | USD 60.8 million |
| Market revenue in 2030 | USD 133.1 million |
| Growth rate | 10.3% (CAGR from 2022 to 2030) |
| Largest segment | 13-24 weeks |
| Fastest growing segment | 0-12 weeks |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
| Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.6% of the global non invasive prenatal testing market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil non invasive prenatal testing market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 36.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non Invasive Prenatal Testing Market Scope
Non Invasive Prenatal Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil non invasive prenatal testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 51.97% in 2022. Horizon Databook has segmented the Brazil non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
Harmony, Panorama, and NACE are produced by Arosa Diagnostics, Natera, & lviomics, respectively. Major distributors and partners for distribution of these products include Fleury Medicine a Saude, Hospital Israelita Albert Einstein, and DASA Group.
Moreover, rising incidence of Down syndrome and other chromosomal abnormalities is anticipated to positively influence the Brazil non-invasive prenatal testing market over the forecast period. Down syndrome is the most prevalent genetic cause of intellectual impairment, with an estimated birth incidence of 14 per 10,000 live births. This also creates an opportunity for launch of NIPTs with lower prices in the region.
Reasons to subscribe to Brazil non invasive prenatal testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil non invasive prenatal testing market databook
-
Our clientele includes a mix of non invasive prenatal testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil non invasive prenatal testing market size, by gestation period, 2018-2030 (US$M)
Brazil Non Invasive Prenatal Testing Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
